Doug talks about trading in public markets, coming from pharmaceutical experience, clinical models, and more.

In Cognito is a podcast designed to be authentic, relaxed, and provide deep insights and thought-provoking questions, minus all the technicalities.

Listen on Spotify:

https://open.spotify.com/show/5XBlwwnbAAbrRd5NgosS1n

Listen on Apple Music:

https://podcasts.apple.com/ca/podcast/in-cognito/id1542426020

Subscribe to the Playlist:

https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1

Doug Drysdale

CEO, Cybin $CYBN

An experienced Corporate Director and CEO: Doug has chaired the Board of a NASDAQ-listed company and, as CEO for the past 12 years, has built and turned-around 3 pharmaceutical companies. During Doug’s 30 years of experience in the healthcare sector, he has formed cohesive management teams, recruited board members, completed 15 corporate acquisitions across three continents and has raised $4 billion of both public and private capital. Doug holds a bachelor’s degree in Microbial and Molecular Biology from the University of East Anglia in the U.K. and was recognized as Entrepreneur of the Year by Ernst and Young, in 2012.